| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.26 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |